The AAP released its 2026 childhood immunization schedule, maintaining routine vaccine recommendations for several diseases despite revised CDC guidelines.

Patients receiving chemotherapy-induced peripheral neuropathy experience persistent, clinically significant symptoms months after treatment.

Higher BMI is linked to worse PROMIS profiles and increased opioid use among patients seeking spine care, despite similar pain intensity across BMIs.

Research shows that reduced catastrophizing partially explains the benefits of mindfulness meditation on pain intensity and interference.

For adolescents diagnosed with episodic migraine, fremanezumab seems to yield greater reduction in migraine and headache days.

A growing measles outbreak draws comments and concern from health care community as CDC official claims it's the "cost of doing business." ...

A significant amount of psychological distress can occur in a considerable portion of women undergoing an unscheduled cesarean delivery.

Many teens skip yearly wellness visits as they transition into adulthood, potentially missing out on care during significant changes.

FDA issues a safety alert for MediHoney and CVS Wound Gel products due to packaging failures that may compromise sterility ...

Ianalumab receives FDA Breakthrough Therapy status for Sjögren disease following positive findings from two phase 3 clinical trial programs.

Perioperative factors, such as preoperative cannabis use and discharge dosing levels, are linked to higher opioid refill rates after otolaryngology surgery.

For adults in the ED with a suspected opioid overdose, bradycardia appears to be associated with increased likelihood of xylazine detection.